TFRI News|October 02, 2019 Terry Fox PROFYLE research shows profiling cancer tumours in real time is giving hope to children and young adolescents previously out of treatment options Early results show that an innovative research program honouring Terry Fox’s legacy is providing treatment opportunities to children and young adults ...
TFRI News|September 30, 2019 2019 Terry Fox Run Challenge: TFRI research teams show immense support, raise nearly $80k for research TFRI-funded researchers showed up in full force for the 39th annual Terry Fox Run, adding a splash of purple to run sites across the country and raisi...
Event|August 02, 2019 Mark your Calendars: TFRI Ontario Node will host annual Research Symposium on Dec. 12, 2019 The Terry Fox Research Institute's Ontario Node is happy to announce that it will be holding its annual Research Symposium on Thursday, Dec. 12 at the...
TFRI News|July 26, 2019 TFRI Launches 2019 Terry Fox Run Challenge the TFRI is proud to launch the 2019 Terry Fox Run Challenge. Our goal for this year is to surpass the amount of money raised in 2018.
Press Release|July 11, 2019 TFRI and partners react to investment of $150M by Federal Minister of Health to create “Team Canada of Cancer Research” The federal Minister of Health, Ginette Petitpas Taylor, announced today an investment of $150 million over five years by the Government of Canada for...
Press Release|July 11, 2019 Federal Minister of Health shows government support for Marathon of Hope Cancer Centres network through $150-million investment to accelerate precision medicine The federal Minister of Health, Ginette Petitpas Taylor, announced today an investment of $150 million over five years by the Government of Canada to ...
Press Release|July 04, 2019 L’Institut de recherche Terry Fox et la Fondation du cancer du sein du Québec s’unissent pour financer à hauteur de 6 M$ une équipe de chercheurs explorant de nouvelles façons de traiter le cancer du sein métastatique Grâce à un nouveau financement de six millions de dollars sur une période de six ans, une équipe de chercheurs basée à Montréal et à Ottawa tentera de...
Press Release|July 04, 2019 Trouver dans le microenvironnement des tumeurs de nouvelles cibles thérapeutiques en vue de personnaliser les traitements contre le cancer Une équipe de spécialistes chevronnés du Princess Margaret Cancer Centre de Toronto est appelée à élargir ses travaux de recherche novateurs sur les e...
Press Release|July 04, 2019 Two top Canadian research teams receive $12 million to solve key cancer challenges The teams, which are based in Toronto and Montreal/Ottawa, will use the funding to dive deep into the unique biology of cancer cells with the hopes of...
Research Highlight|June 14, 2019 A "one-two punch" to wipe out cancerous ovarian cells A team of researchers led by former Terry Fox New Investigator Francis Rodier (University of Montreal Hospital Research Centre - CRCHUM) has developed...
Research Highlight|June 03, 2019 New finding may aid in prediction of aggressiveness of colorectal cancer The deletion of Interleukin-17 receptor (IL-17R), a receptor gene that regulates inflammation, may help predict the aggressiveness of colorectal cance...
Research Highlight|June 03, 2019 TFRI-funded scientists publish snapshot on oncolytic viruses in top scientific journal Members of a long-standing TFRI team focused on developing cancer-killing viruses have published a snapshot article summarizing this promising area of...
Research Highlight|June 03, 2019 Spatial organization of immune cells within tumour microenvironment tied to survival of lung cancer patients “The main concept we wanted to demonstrate is that the spatial organization of immune and tumour cells has a clinical impact. In other words, it’s not...
Research Highlight|June 03, 2019 Terry Fox New Investigator publishes two major papers in top scientific journals In the span of just a couple of months, TFRI New Investigator Dr. Housheng Hansen He has had major papers published in Cell and Nature Communications,...
Research Highlight|June 03, 2019 EZH2 inhibitors could make immunotherapies more effective for a subset of patients with diffuse large B-cell lymphoma A study by a group of BC-based scientists partly funded by the TFRI has discovered mutations responsible for changes in expression of major histocompa...
Research Highlight|June 03, 2019 Team identifies new classification system for Burkitt’s Lymphoma and opens door for more precise treatments A group of scientists partly funded by the Terry Fox Research Institute has discovered a better way to classify Burkitt’s lymphoma (BL), a rare type o...
Research Highlight|June 03, 2019 New research suggests immunotherapy could help nearly 50 per cent of patients with rare mesothelioma A team of scientists partly funded by the Terry Fox Research Institute has shown that nearly half of all patients with peritoneal mesothelioma (PeM), ...
TFRI News|June 03, 2019 TFRI refreshes its visual identity with new logo and website The Terry Fox Research Institute is proud to announce the adoption of a brand-new visual identity as it enters its second decade of research.
Research Highlight|June 03, 2019 Scientists find common brain cancer found in childhood is related to early brain development A new study on the origin and development of pediatric tumours of the cerebellum, such as medulloblastoma, has concluded that these tumours are a diso...
TFRI News|June 03, 2019 Update on the Marathon of Hope Cancer Centres Network There have been a number of activities under way since the Government of Canada’s announcement in March 2019 that it would provide up to $150 million ...
TFRI News|June 03, 2019 Dr. Marla Shapiro joins TFRI Board of Directors The Terry Fox Research Institute is pleased to announce the appointment of Dr. Marla Shapiro to its board of directors.
TFRI News|May 24, 2019 Federal Government Awards $49M to Terry Fox Research Institute and Imagia led Consortium to Accelerate Medical Breakthroughs The new Digital Health and Discover Platform will greatly empower the Marathon of Hope Cancer Centres network, launched by the Terry Fox Research Inst...
Press Release|May 23, 2019 Minister Bains announces investment to accelerate medical breakthroughs that will enable truly personalized health care Today the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development, announced an investment of up to $49 million in the Digi...
Research Highlight|May 14, 2019 Promising findings in pancreatic cancer study highlight the importance of genetic sequencing A study by researchers from TFRI’s Enhanced Pancreatic Cancer Profiling for Individualized Care (EPPIC) research program has led to the discovery of a...
In the Media|April 15, 2019 Media coverage across Canada highlights historic launch of the Marathon of Hope Cancer Centres Media outlets across Canada highlighted the historic launch of the Marathon of Hope Cancer Centres that took place last Friday, April 12th in St. John...
Press Release|April 12, 2019 Cancer centres and researchers in Atlantic Canada join forces to provide precision medicine for cancer patients across region For the first time, leading cancer centres, hospitals and researchers in Atlantic Canada are coming together to help deliver personalized and precisio...
Press Release|April 12, 2019 Inspired by Terry Fox's legacy, Canadian cancer centres join forces for the first time Inspired by the legacy of Terry Fox, today the Terry Fox Research Institute and partners launched a new national network to bring together, for the fi...
TFRI News|April 05, 2019 Media Advisory and Statement Regarding the Marathon of Hope Cancer Centres Network The official launch of the Marathon of Hope Cancer Centres Network will take place on Friday, April 12th in St. John's, N.L., on the same date and pla...
TFRI News|March 20, 2019 Response to the Federal Government's budget announcement regarding $150M for the Marathon of Hope Cancer Centres Network “We are thrilled with today’s announcement by the federal government to support the creation of the Marathon of Hope Cancer Centres. Under this new Te...
In the Media|March 20, 2019 Terry Fox research gets $150m for cancer data network The federal Liberals awarded $150 million to the Terry Fox Research Institute Tuesday, to create an online program for researchers to share cancer inf...
Research Highlight|February 25, 2019 Blocking Type 1 Interferon reduces negative side-effects associated with potent immunotherapy A group of scientists from the TFRI-funded Canadian Oncolytic Virus Consortium (COVCo) has discovered a new way to reduce negative side-effects associ...
In the Media|January 21, 2019 U of A oncology doctor to represent province on Terry Fox Research Institute executive When Dr. David Eisenstat decided to organize a camp charity run in the summer of 1981 inspired by the courageous cancer battle fought by Terry Fox, he...
Research Highlight|January 15, 2019 Use of mTOR inhibitors increases efficacy of herpes virus as an oncolytic therapy A new study by a team of TFRI-funded scientists has found that combining a particular strain of the herpes virus with mTOR inhibitors improves viral r...
Research Highlight|January 15, 2019 Montreal research team identifies SREBF1 as a new, targetable regulatory pathway in prostate cancer The newly discovered pathway, SREBF1, was found to be directly responsible for controlling prostate cancer cell metabolism. It can be targeted with se...
Research Highlight|January 15, 2019 Study reveals genomic differences between long- and short- term survivors of high-grade serous ovarian cancer, advancing potential for individualized treatments Researchers may be one step closer to personalizing treatments for patients with high-grade serous ovarian cancer thanks to a new study that revealed ...
Research Highlight|January 15, 2019 New finding suggests that disrupting interaction between MYC and G9a could stop cancer growth New technology has helped a TFRI-funded multidisciplinary research team identify how MYC – a key driver of human cancer – works, cracking open the pos...
Research Highlight|January 15, 2019 Pan-Canadian prostate cancer team creates robust resource tool to help clinicians with treatment decision-making A pan-Canadian prostate cancer group funded by the TFRI team has created a new tissue microarray (TMA)-based resource to assist clinicians and patholo...
Research Highlight|January 15, 2019 CEST MRI may be able to measure patient response to chemotherapy within 24 hours after first dosage TFRI researchers at Sunnybrook Hospital have found that CEST MRI technology can be used to detect cancer cell death in mice within 24 hours of receivi...
Research Highlight|January 15, 2019 Restoring stem cells to a fetal-like state could provide a therapeutic alternative for acute leukemias A team of TFRI-funded scientists in Vancouver has discovered that restoring a signaling pathway that is prevalent in fetal stem cells but dormant in a...
Research Highlight|January 15, 2019 Study shows benefit of vascular normalization in OV therapy for advanced epithelial ovarian cancer Immunologists at the University of Guelph have discovered that normalizing blood flow into tumours improves efficacy of oncolytic viruses, departing f...
TFRI News|January 15, 2019 Dr. David Eisenstat appointed Alberta Node Leader for TFRI The Terry Fox Research Institute is pleased to announce the appointment of Dr. David Eisenstat as its new node leader for the Province of Alberta.
Research Highlight|January 14, 2019 Researchers discover common markers of tumour hypoxia across 19 cancer types The study, which was partially funded by the TFRI, investigated more than 8,000 human tumours across 19 different cancer types, including prostate tum...
Press Release|December 11, 2018 Outstanding researchers from Montreal, Halifax and Toronto receive $1.35 million to find new treatments for metastatic and ovarian cancers Three outstanding early-career investigators from Montreal, Halifax and Toronto will each receive $450,000 over the next three years to explore new tr...
Research Highlight|December 03, 2018 Identification of new lymphoma sub-group by Terry Fox Research Institute-funded cancer researchers opens door for potential new treatments for hard-to-treat cancer The discovery by BC researchers of a group of bad actors ‘hidden’ within a cohort of good ones may translate into new hope for cancer patients diagnos...
Event|November 14, 2018 TFRI BC Node researchers present their work during 2018 BC Cancer Summit The Terry Fox Research Institute's BC Node will host its annual Node Day on Friday, Nov. 23, 2018 at the Sheraton Wall Centre in Vancouver.
Event|October 16, 2018 Agenda posted for TFRI's Atlantic Node 2018 Cancer Research Conference The Terry Fox Research Institute's Atlantic Node and Beatrice Hunter Cancer Research Institute will be hosting their annual Cancer Research Conference...
TFRI News|October 01, 2018 2018 Terry Fox Run Challenge: TFRI teams show immense support, raise over $90k for research TFRI-funded researchers showed up in full force for the 38th annual Terry Fox Run, adding a splash of purple to run sites across the country and raisi...
Event|September 25, 2018 TFRI Ontario Node Day to be held on December 10, 2018 The Terry Fox Research Institute's Ontario Node will be holding its annual Research Symposium on December 10, 2018 at the MaRS Auditorium (conference ...
Research Highlight|September 10, 2018 Discovery of CD33 in human cord blood cells may affect design of targeted AML therapies This new discovery provides a possible explanation of why some trials that have used CD33 as a potential target for AML therapies have shown specific ...
Research Highlight|September 10, 2018 New discovery answers long-held question about myelodysplastic syndromes In a study published in Nature Communications (June 2018), a team led by Dr. Aly Karsan (BC Cancer) suggests that the key to understanding how both bo...
Research Highlight|September 10, 2018 Co-targeting EphA2/A3 reduces rGBM tumour growth in mice models A bi-specific antibody created by a TFRI-funded team has shown great promise in reducing tumour growth in patients with recurrent glioblastoma (rGBM).
Research Highlight|September 10, 2018 How do doctors really feel about active surveillance? A new study asking health care professionals why many men with low-risk prostate cancer opt for invasive treatments instead of active surveillance rev...
Research Highlight|September 10, 2018 Team identifies CDC25 as a common therapeutic target for triple-negative breast cancer Targeting CDC25 could bring hope to patients with RB1-deficient triple-negative breast cancer (TNBC), according to Toronto-based TFRI-funded team.
Research Highlight|September 10, 2018 Deep-sea bacteria inspire researchers to develop new ways to see, treat tumours The novel dual-biomimetic system created by a TFRI-funded team could serve as a contrast agent that allows researchers to see tumours more clearly, wh...
Research Highlight|September 10, 2018 Scientists use protein found in mosquito virus to suppress RNAi pathway, opening door to make oncolytic viruses more effective By using a protein from a virus first found in Japanese mosquitoes in the 1950s, TFRI-funded researchers have discovered a new way to bypass antiviral...
Event|August 04, 2018 TFRI launches 2018 Terry Fox Run Challenge To register a team for the Terry Fox Run 2018, please visit http://www.terryfox.org/run/teams/, or join our TFRI Headquarters team captained by Dr. Vi...
TFRI News|August 02, 2018 Pilot project network teams report steady progress in first year of working together Over the past year, the Terry Fox Canadian Comprehensive Cancer Centre Network (TF4CN) has fostered unprecedented collaborations, harmonized complex r...
Research Highlight|July 11, 2018 Leukemia researchers discover genetic screening tool to predict healthy people at risk of developing aggressive form of leukemia An international team of leukemia scientists that includes TFRI-funded researchers has discovered how to predict healthy individuals at risk of develo...
Research Highlight|July 01, 2018 MCC sub-project looks to identify biomarkers that could predict success of immunotherapy for leukemia patients A group of cancer investigators from some of the top research institutions in Montreal have come together to launch a groundbreaking project focused o...
Research Highlight|July 01, 2018 Montreal immunotherapy team studying ways to overcome treatment resistance in patients with melanoma Immunologist Dr. John Stagg (Université de Montréal, CR-CHUM) tells us how he and his team will contribute to a Montreal Cancer Consortium (MCC) initi...
Research Highlight|July 01, 2018 Project team in Montreal focuses on reducing side-effects, increasing effectiveness of immune therapies for melanoma patients Dr. Watson and his team are researching how the immune system interacts with melanoma, a disease that has been proven to respond favourably to anti-PD...
In the Media|June 28, 2018 Montreal Cancer Consortium created to develop new strategies Grouping of seven hospitals and research centres will focus on immunotherapy
TFRI News|June 28, 2018 The Terry Fox Research Institute and Montreal research partners form consortium to provide more personalized treatments for cancer patients in Québec Seeking to improve treatments for 18,000 annual cancer patients, leading researchers, cancer centres and hospitals in Montreal and The Terry Fox Resea...
Press Release|June 28, 2018 L’Institut de recherche Terry Fox et leurs partenaires de recherche de Montréal forment un consortium en vue d’offrir des traitements plus personnalisés aux personnes atteintes de cancer au Québec Dans le but d’améliorer les traitements offerts aux 18 000 patients atteints de cancer traités annuellement, les meilleurs chercheurs, centres de canc...
TFRI News|June 12, 2018 Celebrate failure! says TFRI’s leader in new book celebrating Chinese Canadians Dr. Victor Ling is among several prominent Chinese Canadians featured in a newly published 180-page, full-colour book titled Celebration: Chinese Cana...
Press Release|June 05, 2018 Trois des meilleures équipes de recherche canadiennes reçoivent 13 millions de dollars pour résoudre les principaux problèmes liés au cancer Drs. Greg Czarnota (Sunnybrook Health Sciences Centre), David Malkin (Hospital for Sick Children) and David Huntsman (BC Cancer, UBC) (Click here&nb...
TFRI News|June 05, 2018 Three top Canadian research teams receive $13 million to solve key cancer challenges Three outstanding cancer research teams will receive nearly $13 million to continue their investigations into rare tumours, an inherited disorder (Li-...
Research Highlight|June 01, 2018 Harmonizing T-cell production across multiple Canadian sites will potentially bring immunotherapy trials to more patients in more places Ovarian cancer patients across Canada may soon have access to promising immunotherapy trials thanks to a new collaboration fostered by The Terry Fox C...
Research Highlight|May 17, 2018 Erectile dysfunction drugs and flu vaccine may work together to help immune system fight cancer after surgery, study finds A new study led by Dr. Rebecca Auer, a member of TFRI's Oncolytic Virus project and former recipient of a TFRI New Investigator Award, suggests that a...
Research Highlight|May 15, 2018 Breakthrough test uses ctDNA to determine treatment resistance in advanced prostate cancer patients Metastatic castration-resistant prostate cancer (mCRPC) patients are now one step closer to more personalized treatment, thanks to a new test that can...
Research Highlight|May 15, 2018 Medulloblastoma leptomeningeal metastases can also occur through the bloodstream, study finds Findings from a recent study published in Cell are breaking new ground in the pediatric brain cancer world, suggesting medulloblastoma cells can metas...
Research Highlight|May 15, 2018 Researchers develop groundbreaking targeted sequencing pipeline to further precision medicine in lymphoid cancers A cancer research team funded partly by The Terry Fox Research Institute has identified the best method for sequencing gene mutations across several o...
Research Highlight|May 15, 2018 Targeting hypoxia can, in turn, target cancer-initiating cells in colorectal tumours Targeting hypoxia can, in turn, target cancer-initiating cells (C-ICs) in colorectal cancer a study team in Toronto has found. Additionally, the team ...
Research Highlight|May 15, 2018 Blocking donor T cell–mediated TNF? signaling can enhance positive effects of stem cell transplantation A collaboration between Swiss and Canadian research institutes has shown an effective way to enhance human hematopoietic stem and progenitor cell engr...
TFRI News|May 14, 2018 TFRI Now Seeking Applications for its 2019 Cancer Research Programs The Terry Fox Research Institute (TFRI) is seeking applications for two of its prestigious grant programs: The Terry Fox New Frontiers Program and the...
In the Media|May 13, 2018 Watch: TFRI New Investigator featured on CTV Manitoba Dr. Sachin Katyal (CancerCare Manitoba) talks about his unique approach to personalized medicine for brain cancer patients.
Research Highlight|May 10, 2018 TFRI-funded researchers uncover “evolutionary arms race” between cancer and immune system A new study led by a team of TFRI-funded researchers has uncovered the mechanisms through which deadly ovarian cancer cells escape the immune system, ...
Research Highlight|May 01, 2018 Canadian leaders in tumour hypoxia shed light on the role of mTOR signalling in prostate cancer development More findings from TFRI’s prestigious hypoxia team are continuing to change the cancer research landscape when it comes to understanding the role of t...
Event|April 26, 2018 Schedule announced for Atlantic Node's Workshop on "The Many Ways to Science" TFRI's Atlantic node and the Beatrice Hunter Cancer Research Institute will hold a joint workshop on May 25 for researchers and students in Atlantic C...
In the Media|April 11, 2018 Genetic sequencing brings new hope for North Vancouver woman Personalized treatment aids in pancreatic cancer recovery
TFRI News|March 07, 2018 Terry Fox Research Institute awards prestigious grant to help Manitoba cancer researcher tackle deadly brain cancer Brain cancer research in Manitoba has received a boost with news that a local scientist has won a prestigious cancer research award from the Terry Fox...
In the Media|March 06, 2018 New Canadian research aims for tailored treatment of pancreatic cancer Canadian scientists are teaming up with the Terry Fox Research Institute (TFRI) to lead a new $5-million personalized treatment initiative.
Press Release|March 06, 2018 Canadian pancreatic cancer research team provides personalized medicine, new hope to patients Canadian pancreatic cancer researchers are joining forces under a Terry Fox initiative bringing new hope for patients with this deadly disease.
Research Highlight|February 15, 2018 Therapeutic target EZH2 discovered for aggressive, untreatable ovarian cancer affecting young women A Vancouver team led by TFRI-funded investigator Dr. David Huntsman has discovered an important therapeutic target for treating small cell carcinoma o...
Research Highlight|February 15, 2018 Made-in-Canada model for detecting lung cancer saves lives, is a world leader A pan-Canadian TFRI team of cancer researchers has developed a predictive model for detecting early-stage lung cancer in high-risk individuals with si...
Research Highlight|February 15, 2018 Nuclear mTOR acts as a transcriptional regulator of metabolism in prostate cancer, groundbreaking study finds A recent study by TFRI’s cancer metabolism group suggests nuclear mTOR (a kinase) also works as a transcriptional regulator of metabolism in the proli...
Research Highlight|February 15, 2018 Vanadium compounds enhance efficacy of oncolytic viruses when used in combination therapy A new class of compounds is generating excitement for its ability to enhance the efficacy of oncolytic viruses (OVs) and to stimulate the immune respo...
Research Highlight|February 15, 2018 Ultrasound-stimulated microbubbles enhance radiation effect on prostate cancer cells What if there was a way to make cancer cells more susceptible to radiation therapy without damaging healthy cells? New findings from Toronto researche...
Press Release|February 15, 2018 Study finds mitochondrial mutations drive prostate cancer aggression While nuclear mutations are widely acknowledged as a driver of cancer tumours, the role of maternally inherited mitochondrial genome mutations has not...
TFRI News|February 08, 2018 2017 Marathon of Hope Lecture Series As part of its 10th anniversary celebration, TFRI presented a session titled The Marathon of Hope Lecture Series at the Canadian Cancer Research Confe...
Event|January 19, 2018 2017 TFRI Ontario Node Day Photos The annual Terry Fox Research Institute’s Ontario Node Research Symposium took place Monday, Dec. 4, 2017 at the MaRS Discovery Centre in Toronto. Ph...
Research Highlight|January 03, 2018 New study shows viruses and checkpoint inhibitors work together to cure resistant breast cancer in mice A new study led by TFRI-funded researchers at The Ottawa Hospital (TOH) and the University of Ottawa suggests that a combination of two immunotherapie...
TFRI News|December 07, 2017 Milestone Videos: TFRI Celebrates 10th Anniversary This was a big year for the Terry Fox Research Institute: 2017 marked our 10th anniversary. Here are two videos we created to celebrate this milestone...
Press Release|November 24, 2017 Canadian pediatric researchers, funders join forces, commit $16.4M to give young people across the country a fighting chance against cancer For the first time in Canadian history, more than 30 pediatric cancer research and funding organizations have joined forces through Terry Fox PROFYLE,...
In the Media|November 23, 2017 CancerCare Manitoba joins research project that offers hope for kids with rare cancers PROFYLE project brings together experts from across Canada to network, discover new treatments
In the Media|November 23, 2017 Canada-wide program aims to get young cancer patients faster access to new therapies If Terry Fox were diagnosed today, he would fall among the 20 per cent of young cancer patients who run out of treatment options. But now, patients li...
In the Media|November 23, 2017 Children out of cancer treatment options offered hope by new Terry Fox program 'It presents options and time,' says mother of 8-year-old girl now on new cancer drug
TFRI News|October 26, 2017 B.C. Lung Screen Trial recruiting 2,000 people for cancer screening study The B.C. Lung Screen Trial at Vancouver General Hospital is currently recruiting 2,000 individuals from the Lower Mainland who are between 55 and 80 y...
Research Highlight|October 18, 2017 Terry Fox research team’s model for detecting lung cancer saves lives, is a world leader: study A pan-Canadian team of cancer researchers has developed a predictive model for detecting early-stage lung cancer in high-risk individuals with signifi...
TFRI News|September 06, 2017 Four premier TFRI investigators will present Marathon of Hope talks at CCRC TFRI is pleased to announce that it will be presenting a concurrent session (D6 in program) at the upcoming Canadian Cancer Research Conference featur...
TFRI News|September 06, 2017 TFRI's 8th ASM focuses on potential of precision medicine TFRI’s one-day 8th Annual Scientific Meeting on Saturday, Nov. 4 in Vancouver will feature talks related to the theme of the potential of precision me...
TFRI News|September 06, 2017 It’s not too late to join a Terry Fox Run research team! The annual Terry Fox Run is just around the corner and our purple-shirted research teams, their friends and families will be out in full force again t...
Research Highlight|September 06, 2017 Canadian, international researchers find new candidate drivers, subtype diversity in study of whole-genome landscape for children’s brain cancer A new study has analyzed hundreds of sequenced medulloblastoma (MB) samples, identifying new targets that could give children with this disease less h...
Research Highlight|September 06, 2017 Vancouver team identifies new class of molecules with potential in treating metastatic prostate cancer A recent study by a prolific TFRI-funded team has demonstrated that disrupting ERG transcriptional activity is sufficient to suppress the major charac...
Research Highlight|September 06, 2017 Vaccine shows promise in models, eradicates intra-abdominal tumours in over 90 per cent of mice Ontario cancer researchers have found that an oncolytic virus may lead to a promising new therapy option for patients with peritoneal carcinomatosis, ...
Research Highlight|September 06, 2017 Why does relapse occur in aggressive leukemia? Canadian researchers crack the case A team of Canadian cancer researchers has shown that rare, therapy-resistant leukemia stem cells are already present at diagnosis in patients who expe...
Research Highlight|September 06, 2017 Study finds diffuse optical spectroscopic (DOS) texture features can predict breast cancer response prior to neoadjuvant chemotherapy Diffuse optical spectroscopic texture features can predict breast cancer response to neoadjuvant chemotherapy in locally advanced breast cancer patien...
Research Highlight|September 06, 2017 TP53 polymorphisms and MDM2 SNP309 are not correlated with pre-menopausal cancer risk, study suggests While significant accolades are given to scientists who discover genetic mutations that are linked to cancer, it is equally important to determine fac...
Research Highlight|September 06, 2017 Discovery of seven new ovarian cancer subtypes opens door for more targeted treatments The discovery of seven new genetic subtypes of ovarian cancer may lead to targeted treatments for women diagnosed with this disease, including those w...
Research Highlight|September 06, 2017 Subtype-specific alterations in BCL2 linked to poor post-treatment outcomes in non-Hodgkin lymphoma Subtype-specific alterations in a driver gene for non-Hodgkin lymphoma (BCL2) is strongly associated with poor patient outcomes after treatment.
Press Release|September 05, 2017 Three 2017 PPG awards announced for cutting-edge projects in leukemia, oncolytic viruses, nanoparticle imaging The Terry Fox Research Institute has invested nearly $21.5-million to renew three 2017 Terry Fox New Frontiers Program Project Grants (PPGs).
Event|August 28, 2017 Grab your running shoes: Join us on Sept. 17 for the annual Terry Fox Run This year's annual Terry Fox Run will be held at locations across Canada on Sunday, Sept. 17. Everyone is welcome to participate, regardless of age, a...
Research Highlight|July 01, 2017 Collaborative generation, sharing and analysis of data could make precision medicine available for patients with colorectal cancer The TF4CN is allowing scientists in two of Canada’s biggest cancer research centres to work together like never before to tackle four distinct project...
TFRI News|June 30, 2017 Canadian hero Terry Fox’s cancer research legacy lives on: VICE Sports Two features articles published by VICE Sports for Canada 150 are calling Terry Fox the most important athlete in Canadian history whose cancer resear...
Research Highlight|June 30, 2017 Lung cancer screening may save both lives and money, study suggests New research from a TFRI-funded team suggests screening for lung cancer could save money – and lives – especially if it also identifies other tobacco-...
TFRI News|June 22, 2017 One in two Canadians will get cancer, but research offers hope for cures Terry’s dream was to fund research to cure cancer, and he inspired us with that dream. We believe that it is through research that cures to cancer wil...
Research Highlight|June 07, 2017 ‘Better information helps make better decisions’: Research team takes prostate imaging to the next level In this blog post, Dr. Foster details the ground breaking work the group is doing in prostate cancer imaging through The Terry Fox New Frontiers Progr...
In the Media|May 29, 2017 Canada 150: Dr. Victor Ling made a huge breakthrough in fighting drug-resistant cancers In 1971, Dr. Victor Ling was frustrated and full of doubt. It was an unusual period for Ling, who is known for his optimism about finding a cure for c...
TFRI News|May 29, 2017 TFRI's Dr. Victor Ling recognized for breakthrough in fighting drug-resistant cancers Dr. Victor Ling, president and scientific director of The Terry Fox Research Institute, has been recognized by The Vancouver Sun for his breakthrough ...
Research Highlight|May 24, 2017 MATE2 expression a negative predictive biomarker to metformin’s efficacy in cancer treatment, study suggests The drug metformin is typically used to treat Type 2 diabetes, and some cancer patients have shown improved outcome when given the drug. A recent stud...
Research Highlight|May 24, 2017 Groundbreaking study sheds light on signaling molecules that control human hematopoietic stem cell survival and growth TFRI’s long-funded program project on human leukemia has made groundbreaking progress in the quest to expand human blood stem cells for therapeutic pu...
Research Highlight|May 24, 2017 Novel 17-gene test predicts if patients with aggressive leukemia will respond to treatment or not What if there was a way to predict if leukemia patients would respond to standard treatment or not? A TFRI-funded team has developed a novel, 17-gene ...
Research Highlight|May 24, 2017 Canadian study identifies predictive genomic signature for high-risk prostate cancer Understanding why some prostate cancer tumours are indolent while others eventually kill patients is the focus of many within the global cancer resear...
Research Highlight|May 24, 2017 Complement inhibitors decrease neutralization of some oncolytic viruses, increase treatment efficacy The use of oncolytic viruses to stimulate a patient’s immune system as well as directly kill tumour cells is a novel approach to eradicating cancer, b...
Research Highlight|May 18, 2017 B.C. team study detects rare ovarian cancer mutation in ctDNA of patients The finding by a B.C. team studying rare and forme fruste tumours is important in that it may help to identify women at risk of relapse for the diseas...
TFRI News|May 17, 2017 Terry Fox Foundation is media outlet’s top pick for donating to cancer research An article published in The National Post in mid-May has identified the Terry Fox Foundation as one of the best places to donate to cancer research in...
Event|April 28, 2017 Annual cancer research workshop sponsored by Beatrice Hunter Cancer Research Institute and the TFRI Atlantic Canada’s annual cancer research workshop Research and Collaboration in Oncology will be held May 26 in Halifax. The workshop will feature key...
Press Release|April 25, 2017 Four 2017 New Investigator award recipients announced Awards to four New Investigators were recently made, with each award valued at $450,000 for a term of three years. Recipients are: Dr. Housheng Hansen...
Research Highlight|March 24, 2017 New test identified to detect men at high risk of aggressive prostate cancer TFRI New Investigator Paul Boutros is among a team of researchers who have found a new test that can help to determine men at high risk for aggressive...
In the Media|February 23, 2017 Saint John to head national cancer study Oncologist and UNB Saint John professor picked by Terry Fox Research Institute
In the Media|February 22, 2017 Five-year study to examine treatments for people with multiple myeloma A New Brunswick led team has been awarded $5 million from the Terry Fox Research Institute to find better treatments for people with an incurable form...
TFRI News|February 15, 2017 TFRI launches Pan-Canadian initiative to bring new hope to multiple myeloma patients New Brunswick-led national research team aims for tailored treatments for patients with incurable multiple myeloma through Terry Fox Research Institut...
TFRI News|February 15, 2017 Cambridge MP Bryan May congratulates TFRI and partners in House of Commons In the House of Commons today, Cambridge MP Bryan May congratulated TFRI and its joint pilot project partners -- The Princess Margaret Cancer Centre a...
Press Release|February 02, 2017 The Terry Fox Research Institute, Princess Margaret Cancer Centre and BC Cancer Agency launch innovative pilot project to accelerate precision medicine in Canada The Terry Fox Research Institute and two leading cancer centres in Canada -- the Princess Margaret Cancer Centre and the BC Cancer Agency -- have l...
Research Highlight|January 04, 2017 Inexpensive algorithm will increase accuracy in subclassification of ovarian cancer, aid in matching treatment to histotype A biomarker study by COEUR (Canadian Ovarian Experimental Unified Resource), TFRI’s pan-Canadian ovarian cancer research team, examining over 2,000 ov...
Research Highlight|January 03, 2017 Hypoxia team members make game-changing findings about how tumour cells control oxygen consumption Members of TFRI’s hypoxia research team have made some game-changing findings when it comes to understanding how tumour cells regulate their ...
Research Highlight|January 03, 2017 TFRI-funded team identifies two new inhibitors that show potential in combination therapies for adult brain cancer A study by TFRI researchers investigating potential new drugs to treat glioblastoma (GBM) patients has identified an epigenetic-modifier drug which, t...
Research Highlight|January 03, 2017 How differences in the germline influence the type of prostate cancer that arises When it comes to treating prostate cancer, the news is predominantly positive: a combination of early detection and treatment by radiotherapy and surg...
Research Highlight|January 03, 2017 Personalizing treatment for patients with the most common malignant childhood brain tumour A TFRI-funded research team studying the most common type of brain tumour in children recently demonstrated the benefits of personalizing treatment ...
Research Highlight|January 03, 2017 Clusterin knockdown sensitizes prostate cancer cells to therapies by modulating mitosis A study by a TFRI-funded team based at the Vancouver Prostate Centre has found that silencing a key driver of castrate-resistant prostate cancer and r...
Research Highlight|December 14, 2016 Whole genome sequencing study helps BC team learn how aggressive follicular lymphoma occurs in patients Follicular lymphoma (FL), the second most common form of non-Hodgkin lymphoma, is a largely incurable disease of B cells, yet in many cases, because o...
Research Highlight|December 09, 2016 Stem cell-based test predicts leukemia patients' response to therapy to help tailor treatment TORONTO, Canada – Dec. 7, 2016 – Leukemia researchers at Princess Margaret Cancer Centre, with funding from Terry Fox and others, have developed a 17-...
Event|December 08, 2016 Ontario Node Symposium in Toronto draws large crowd; images posted TFRI's Ontario Node Research Symposium held on Monday, December 5 in Toronto drew over 400 people this year from across the province and beyond to hea...
Event|October 28, 2016 Joint 2016 BHCRI/TFRI Cancer Research Conference in Atlantic Canada set for November 7-8th in Halifax The Beatrice Hunter Cancer Research Institute and the Terry Fox Research Institute will hold their annual joint conference on November 7-8th at the Lo...
Research Highlight|October 05, 2016 How a unique zebrafish facility at Dalhousie is supporting two TFRI-funded projects Our current Zebrafish Core Facility is one of the largest of its kind in Canada and on par with the largest facilities in North America. We have the c...
TFRI News|September 29, 2016 2016 Terry Fox Run update: TFRI teams show immense support, with over $105,000 raised through team/t-shirt challenge TFRI-funded research teams from coast to coast showed their true colours this year, turning out by the dozens in researcher-designated purple T-shirts...
Research Highlight|September 29, 2016 Groundbreaking study finds miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells A groundbreaking new publication by Dr. John Dick’s TFRI-funded team has confirmed that miRNA expression patterns are predictive of disease outcome in...
Research Highlight|September 29, 2016 Montreal team discovers new molecular pathway key to understanding fat/cancer links A new publication from the TFRI-funded team at McGill University (Goodman Cancer Centre) studying oncometabolism and molecular pathways is bringing ne...
News|September 29, 2016 Dual expression study helps identify B-cell lymphoma patients at high risk for CNS relapse Despite improvements in outcome in diffuse large B-cell lymphoma (DLBCL) in the monoclonal antibody rituximab treatment era, central nervous system (C...
Research Highlight|September 29, 2016 Ovarian cancer: Mapping the clonal spread A team of B.C.-based, TFRI-funded scientists are breaking new ground with a recent study that tracked the clonal spread and intraperitoneal mixing of ...
Research Highlight|September 29, 2016 New class of small molecules enhances OV replication An innovative paper by Dr. Jean-Simon Diallo (TFRI-funded Canadian Oncolytic Virus Consortium (COVCo) and collaborators Drs. Jeffrey Smith and Christ...
Research Highlight|September 29, 2016 Ultrasound, imaging effective tools to monitor treatment response Terry Fox-funded researchers have made a critical finding in monitoring breast cancer patient response to chemotherapy treatment: patient response to ...
Press Release|September 07, 2016 TFRI ANNOUNCES 2016 FUNDING COMPETITION AWARD RECIPIENTS Vancouver, BC – Six outstanding Canadian research teams will use $27.3 million in new funding to engineer precision medicines for patients whose cance...
Research Highlight|July 15, 2016 “Smart” nanoparticle (PEARLs) a promising gem to target and treat tumours with greater precision Dr. Gang Zheng and a team of biomedical researchers have discovered a "smart," organic, biodegradable nanoparticle that uses heat and light in a contr...
Research Highlight|July 14, 2016 Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood International stem cell scientists, co-led in Canada by Terry Fox-funded scientist Dr. John Dick and in the Netherlands by Dr. Gerald de Haan, have di...
Research Highlight|June 14, 2016 Study by TFRI-funded team underscores importance of accurate diagnosis for rare ovarian and other cancers Terry Fox-funded cancer researchers in BC led an international study to develop a new method to improve diagnosis of a rare sub-type of ovarian cancer...
Research Highlight|June 04, 2016 Terry Fox researcher leads international conference on ‘devastating’ cancer predisposition syndrome Terry Fox-funded researcher Dr. David Malkin, The Hospital for Sick Kids, Toronto, Ontario, was in Columbus, Ohio this week to co-lead the 2016 Intern...
TFRI News|April 22, 2016 Dr. Victor Ling receives lifetime achievement award Congratulations to Dr. Victor Ling, TFRI's President and Scientific Director, who has been honoured with the LifeSciences BC Dr. Don Rix Award for Lif...
TFRI News|March 15, 2016 Rolland (Rolly) Murray Fox: 1935-2016 Rolland (Rolly) Murray Fox was born March 22, 1935 in Winnipeg, Manitoba. Rolly was the third of nine children born to Rodney Fox and Bertha (Shale) F...
TFRI News|March 09, 2016 A message from the Fox family: Rolly Fox Our Dad and Grandpa is no longer telling jokes. Rolland Murray Fox died late afternoon on March 8th while listening to a little Hank Williams. He fulf...
TFRI News|February 22, 2016 A message from Rolly Fox “I would like to express to all of the wonderful Terry Foxers in Canada and around the world, a heartfelt thank you for the many beautiful messages, l...
Research Highlight|February 12, 2016 Blue Light Shines Brightly as a Highly Useful Oral Cancer Surgery Tool Terry Fox-funded researchers find that fluorescence visualization may drastically reduce cancer recurrence by clearly differentiating cancer cells fro...
TFRI News|January 26, 2016 Rolly Fox - Fox family statement It is with heavy hearts that we wish to share with Terry Foxers from coast to coast and around the world that our Dad and Grandfather, Rolland (R...
Research Highlight|January 14, 2016 Biology of tumour changes when childhood brain cancer recurs, Canadian study finds New research co-funded by the Terry Fox Research Institute offers a simple explanation as to why new and experimental treatments fail for children wit...
TFRI News|November 19, 2015 Full house at 'Genomics and Cancer' Symposium Vancouver -- Around 350 people attended the Gairdner Foundation 'Genomics and Cancer' Symposium at UBC on 17 November. An international set of present...
TFRI News|November 10, 2015 Terry Fox researchers recognized for contributions to cancer research Montreal – TFRI extends their congratulations to two Terry Fox-funded researchers who received awards at this week’s Canadian Cancer Resea...
TFRI News|November 09, 2015 Researchers turn out for Terry Fox Morning Run Cancer researchers attending this year's Canadian Cancer Research Conference in Montreal rose early for the Terry Fox Early Morning Run. Darrell...
TFRI News|October 14, 2015 Terry Fox research team sets the bar high raising $35,000 in anniversary year To honour the 35th anniversary of the Marathon of Hope, many Terry Fox-funded research teams across Canada took up the challenge of fundraising for th...
TFRI News|September 21, 2015 Photos from the 35th anniversary Terry Fox Run Terry Fox-funded researchers from across the country took part in the 35th anniversary Terry Fox Run on Sept. 20, 2015. Here are a selection of photo...
Press Release|September 16, 2015 $16-million from supporters and partners fuels research to improve detection, treatment for high-risk, inherited cancers In this 35th anniversary year of the Terry Fox Marathon of Hope, a $16-million injection of funding from the Terry Fox Foundation and three new resear...
In the Media|September 11, 2015 FOX 35: Vitamin C crucial part of cancer breakthrough – funded by Fox Could Vitamin C restore the balance to the epigenome in the blood cancer and become a therapeutic benefit to help those in need?
TFRI News|September 04, 2015 Darrell Fox cycling to Mount Terry Fox September 4, 2015 -- Darrell Fox is cycling 350km from Kamloops to Valemount ahead of the Fox Family hike up Mount Terry Fox on Sunday, September 6. ...
TFRI News|September 02, 2015 Fox Family to hike to summit of Mount Terry Fox The family of Canadian icon Terry Fox will reflect on 35 years of dedication to cancer research and Terry’s memory when they and 50-plus “Terry Foxers...
TFRI News|August 31, 2015 Terry Fox Run 2015 The 2015 Terry Fox Run takes place on Sunday, September 20. Many Terry Fox-funded research teams have signed-up to mark the 35th anniversary of Terry'...
TFRI News|August 26, 2015 Quebec researchers to fight a deadly form of children’s leukemia and to test a new way to kill prostate cancer cells Terry Fox spent months in a pediatric ward for his bone cancer. Today, two of three Quebec researchers to receive funding from Terry Fox will pursue n...
Press Release|August 19, 2015 TFRI BC researchers aim to improve treatment, diagnostics for leukemia and lymphoma Vancouver, BC --Terry Fox’s research legacy continues in British Columbia 35 years after he set out on his Marathon of Hope. Two local cancer research...
Press Release|August 19, 2015 Studying bone cancer in dogs may yield new therapies for treating osteosarcoma patients Guelph, Ontario - For the first time, funds raised for cancer research by the Terry Fox Foundation through the annual Terry Fox Run will be used to st...
TFRI News|August 05, 2015 Manitoba marks first Terry Fox Day Manitoba marked the first Terry Fox Day on August 3, 2015. Terry was born in Winnipeg, MB, in 1958 and the province is the first to name a day in his ...
Research Highlight|July 24, 2015 Supporting future leaders in cancer research in Atlantic Canada *This article by Dr. Alamelu Bharadwaj is part of the old TFRI Blog. Basic science research is complex and time consuming but is the most ...
In the Media|July 10, 2015 Canadian study to use two cancer-fighting viruses in world first Ontario researchers have launched the first clinical trial that will use two, custom-made, cancer-fighting viruses to stimulate the immune system into...
Research Highlight|July 10, 2015 Cancer patients treated in world-first clinical trial of viral therapy Terry Fox-funded researchers are key members of a Canadian team to have launched the world’s first clinical trial of a new therapy that uses a combina...
TFRI News|June 08, 2015 Ontario legislature supports Terry Fox Day The Ontario legislature has completed third reading of a bill calling for the second Sunday after Labour Day to be designated Terry Fox Day. Ontario M...
TFRI News|June 05, 2015 BC Node hosts MLAs Victoria , BC May 26 -- BC MLAs and ministers had an opportunity to hear about the current state of cancer research from TFRI-BC Node Regional Advisor...
TFRI News|May 27, 2015 Support grows for a space to share Terry's story The Fox family have enlisted the head of credit union Vancity to investigate options for a centre to honour Terry Fox and to display the thousands of ...
TFRI News|May 26, 2015 TFRI Prairie Node Symposium Day The TFRI Prairie Node Symposium Day took place on June 9, 2015 in Winnipeg, MB. Nearly 100 people attended the event, hosted by Prairies Node lea...
TFRI News|May 12, 2015 Annual Scientific Meeting Over 200 researchers enjoyed warm Newfoundland hospitality when they attended TFRI's 6th Annual Scientific Meeting in St. John's Newfoundland.
Research Highlight|April 23, 2015 Viruses and drugs combine to form potent anti-cancer therapy Ottawa, ON -- Terry Fox-funded researcher, Dr. Jean-Simon Diallo and his colleagues at the Ottawa Hospital Research Institute have discovered that com...
Research Highlight|April 20, 2015 Pancreatic cancer loses viral defences when talking with supporting cells Ottawa, ON -- Terry Fox funded researchers in Ottawa have found a way to make pancreatic cancer cells more vulnerable to cancer-killing viruses, known...
TFRI News|April 13, 2015 $35 million goal for Marathon of Hope Anniversary This weekend marked the 35th anniversary of the start of Terry Fox's Marathon of Hope, when he set off from St. John's NL on April 12, 1980. In the 35...
TFRI News|April 07, 2015 Museum of History - Terry Fox exhibit To mark the 35th anniversary of Terry Fox's Marathon of Hope, the Canadian Museum of History has opened a special exhibit Terry Fox - Running to the H...
TFRI News|January 15, 2015 Congratulations to TFRI researcher on $25 million funding for cancer biotherapeutics initiative The Terry Fox Research Institute congratulates Dr. John Bell and his team on their award of $25 million in funding from the Government of Canada's Net...
TFRI News|December 09, 2014 Ontario Node Symposium Day Over 260 people attended the first TFRI-Ontario Node Research Symposium on Monday, Dec. 8, at the the MaRS Discovery Centre, Toronto.
TFRI News|November 24, 2014 The Terry Fox Foundation welcomes Britt Andersen as new Executive Director The Terry Fox Foundation is pleased to announce the appointment of Britt Andersen as its new Executive Director, effective November 24, 2014.
TFRI News|November 14, 2014 Taiwan President Ma Ying-jeou will join Darrell Fox and West Vancouver MP John Weston in Taipei Terry Fox Run The Terry Fox Foundation (TFF) is pleased to announce that Taiwan President Ma Ying-jeou will participate in the Terry Fox Run being held in Taipei, T...
Research Highlight|November 13, 2014 Glioblastoma team makes good progress with nine compounds in the pipeline Calgary, Alberta -- Glioblastoma (GBM) is a deadly adult brain cancer that has eluded major treatment advances. Our Terry Fox pan-Canadian project, le...
TFRI News|October 23, 2014 BC legislature supports Terry Fox Day Victoria, BC Oct. 23, 2014 -- BC legislature calls for the second Sunday after Labour Day to be designated Terry Fox Day
TFRI News|October 23, 2014 TFRI and Team Finn Foundation form partnership TFRI and the Team Finn Foundation have formed a new partnership to build a business plan for a new research initiative focused on young persons’ canc...
Press Release|September 10, 2014 $14.6-million investment kicks off 2014 Terry Fox Run Terry Fox Foundation takes aim at hard-to-treat cancers and personalized treatment with multimillion-dollar research investment at six leading Toronto...
TFRI News|July 28, 2014 Staff, management at Montreal hotel donate $1,000 to Terry Fox research TFRI’s fifth annual scientific meeting (ASM) in Montreal, Quebec this spring wrapped up with a surprise cash donation of a $1,000 for Terry Fox resear...
Press Release|March 06, 2014 Innovative new investigators to study cancer growth and response to treatment Three promising Canadian cancer researchers, two in Ontario and one in Quebec, have been awarded a total of $1.35 million under the Terry Fox Research...
Research Highlight|February 17, 2014 Terry Fox-funded lymphoid cancer group discovers new, recurrent genetic mutation in two kinds of lymphoma Researchers funded by the Terry Fox Foundation and based at the BC Cancer Agency’s Centre for Lymphoid Cancer in Vancouver have discovered a new, recu...
TFRI News|October 28, 2013 Canadian Cancer Research Alliance honours Dr. Ling with Exceptional Leadership in Cancer Research award TFRI’s president and scientific director Dr. Victor Ling will be recognized at an awards dinner on Nov. 5th in Toronto for his Exceptional Leadership ...
TFRI News|October 09, 2013 The Terry Fox Foundation tackles "unmet cancer needs" with $13.6-million for rare tumour, lymphoma and early-stage prostate and esophogeal cancer research The Terry Fox Foundation tackles "unmet cancer needs" with $13.6-million for rare tumour, lymphoma and early-stage prostate and esophogeal cancer rese...
Press Release|September 05, 2013 Terry Fox Research Institute-Led Study Develops New Clinical Tool That Accurately Classifies, Nine Out Of Ten Times, Benign And Malignant Spots On Lung CT Scans Of Smokers Terry Fox Research Institute-Led study develops new clinical tool that accurately classifies, nine out of ten times, benign and malignant spots on lun...
In the Media|September 04, 2013 Made-in-Canada software helps better predict cancerous lesions in CT scans A team of Canadian researchers led by the Terry Fox Research Institute has developed new software that can accurately identify whether a lesion on the...
Research Highlight|June 27, 2013 Study extended to June 2015 Study extended to June 2015. The Terry Fox Research Institute and partners inject $1.5 million into national lung cancer study to answer additional ke...
TFRI News|April 10, 2013 Terry Fox Research Institute and Saskatchewan Health Research Foundation Partner On Innovative Tumour-Targeting Terry Fox Research Institute and Saskatchewan Health Research Foundation Partner On Innovative Tumour-Targeting Approach For Treating Cancer
Press Release|October 11, 2012 The Terry Fox Foundation provides $13.4 million for world-class, novel research into fighting cancer with viruses The Terry Fox Foundation provides $13.4 million for world-class, novel research into fighting cancer with viruses and finding ways to treat acute leuk...
TFRI News|September 06, 2012 New national initiative unites university students from coast to coast in honour of Canadian hero Terry Fox's legacy for cancer research New national initiative unites university students from coast to coast in honour of Canadian hero Terry Fox's legacy for cancer research
TFRI News|July 25, 2012 New pan-Canadian Terry Fox Research Institute network receives close to $4-million to find better tools to treat prostate cancer New pan-Canadian Terry Fox Research Institute network receives close to $4-million to find better tools to treat prostate cancer
TFRI News|July 09, 2012 2011 New Investigator awardees receive $1.7 million 2011 New Investigator awardees receive $1.7 million
TFRI News|June 26, 2012 McGill trainees earn top honours at TFRI Scientific Meeting Poster Competition McGill trainees earn top honours at TFRI Scientific Meeting Poster Competition
Press Release|June 05, 2012 Canadian "dream team" to tackle deadly brain cancer with $8.2 million from The Terry Fox Research Institute Canadian "dream team" to tackle deadly brain cancer with $8.2 million from The Terry Fox Research Institute, The Terry Fox Foundation and its partners...
TFRI News|May 01, 2012 Terry Fox Research Institute announces appointment of Iain R.V. MacKay to its Board of Directors Terry Fox Research Institute announces appointment of Iain R.V. MacKay to its Board of Directors
Research Highlight|April 01, 2012 Terry-Fox funded research at Princess Margaret Hospital finds oxygen in tumours predicts prostate cancer recurrence Terry-Fox funded research at Princess Margaret Hospital finds oxygen in tumours predicts prostate cancer recurrence
TFRI News|March 21, 2012 Terry Fox inducted into Canadian Medical Hall of Fame as "medical hero" Terry Fox inducted into Canadian Medical Hall of Fame as "medical hero"
News|February 22, 2012 Signing in Singapore strengthens research capacity and Terry Fox legacy Signing in Singapore strengthens research capacity and Terry Fox legacy
Press Release|February 06, 2012 Study will identify tumour subtypes for better treatment. TFRI invests $750,000 in national childhood brain cancer project Study will identify tumour subtypes for better treatment. TFRI invests $750,000 in national childhood brain cancer project
TFRI News|February 06, 2012 Queen's Diamond Jubilee Medal honours legacy of Terry Fox Queen's Diamond Jubilee Medal honours legacy of Terry Fox
TFRI News|December 12, 2011 BC surgeon Dr. Nadine Caron delivers keynote address at inaugural TFRI-BC Node Research Day BC surgeon Dr. Nadine Caron delivers keynote address at inaugural TFRI-BC Node Research Day
TFRI News|December 10, 2011 Scientists brave heavy rain in Toronto to run in memory of Betty Fox Scientists brave heavy rain in Toronto to run in memory of Betty Fox
TFRI News|November 02, 2011 Terry Fox Run dollars provide $12.7 million to Canadian scientists and health research centres for breakthrough cancer research Terry Fox Run dollars provide $12.7 million to Canadian scientists and health research centres for breakthrough cancer research
TFRI News|October 13, 2011 New Terry Fox Research Institute initiative seeks to change the way ovarian cancer is diagnosed and managed worldwide New Terry Fox Research Institute initiative seeks to change the way ovarian cancer is diagnosed and managed worldwide
Press Release|May 26, 2011 Pan-Canadian Surgical Study Offers New Hope for Patients with Early-Stage Oral Cancer Pan-Canadian Surgical Study Offers New Hope for Patients with Early-Stage Oral Cancer
Research Highlight|April 20, 2011 Ottawa resident receives excellent prognosis after study detects early lung cancer Ottawa resident receives excellent prognosis after study detects early lung cancer
Research Highlight|April 12, 2011 Investment helps novel drug for colorectal cancer move forward into clinical trial to determine tolerability for patients Investment helps novel drug for colorectal cancer move forward into clinical trial to determine tolerability for patients
TFRI News|December 08, 2010 Terry Fox Foundation awards four promising new investigators with nearly $2 million Terry Fox Foundation awards four promising new investigators with nearly $2 million
TFRI News|December 02, 2010 TFRI Launches Prairie Node on Thursday Dec. 2, 2010 TFRI Launches Prairie Node on Thursday Dec. 2, 2010
Press Release|September 16, 2010 The Terry Fox Foundation announces $14.8-million national investment in cancer research through new partnership The Terry Fox Foundation announces $14.8-million national investment in cancer research through new partnership with Canadian Institutes of Health Res...
Press Release|September 08, 2010 Genome sciences leader Dr. Marco Marra joins executive team of the Terry Fox Research Institute Genome sciences leader Dr. Marco Marra joins executive team of the Terry Fox Research Institute
TFRI News|June 23, 2010 Terry Fox Research Institute Expands Early Detection Lung Study to Newfoundland & Labrador Terry Fox Research Institute Expands Early Detection Lung Study to Newfoundland & Labrador
Press Release|June 21, 2010 Excellence and Terry's story inspires inaugural TFRI poster award winner Excellence and Terry's story inspires inaugural TFRI poster award winner
Press Release|April 12, 2010 Improving Cancer Outcomes Through Translational Research Is Priority For New Terry Fox Research Institute Node and Atlantic Partners Improving Cancer Outcomes Through Translational Research Is Priority For New Terry Fox Research Institute Node and Atlantic Partners